EUVIMEDEUVIMED entdecken
Crossref

L26/P-414 In Vitro Growth of human primordial follicles: Effect of Trigonelline hydrochloride on follicle activation and growth

A. Ajlan, A. Chibnall, V. Srsen, Y. Odey, R.A. Anderson, E.E. Telfer

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.748 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A. Ajlan und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does Trigonelline hydrochloride (TH) supplementation during culture of human ovarian cortex enhance primordial follicle activation, and quality of isolated preantral follicles for further growth? Summary answer Culture of ovarian fragments with 0.5 µM TH supported activation of follicles, yielding larger diameter secondary follicles with improved growth capacity during individual culture. What is known already A culture system has been developed to support activation of primordial follicles in human ovarian cortical tissue, followed by growth of isolated follicles to maturity. Improving the number and health of follicles isolated after step 1 is the goal of this work. Studies in mice and humans indicate that the natural alkaloid Trigonelline promotes primordial follicle activation in vitro and improves oocyte quality. This study evaluated the effects of supplementing initial culture medium with Trigonelline hydrochloride on human primordial follicle activation and on the subsequent health and growth of isolated preantral follicles cultured under TH free condition. Study design, size, duration Fresh ovarian cortical biopsies were obtained with informed consent from 7 women aged 30–36 years (33.7 ± 2.1 years) undergoing elective caesarean section. Tissue fragments (∼3 × 1 × 0.5 mm) were cultured for 8 days in control medium alone (n = 40) or supplemented with TH 0.5 µM (n = 19) or 2.5 µM (n = 17). Secondary follicles were then mechanically isolated and individually cultured in 96-well V-shaped plates for up to 15 days without TH. Participants/materials, setting, methods Fragments from each treatment group and uncultured controls, were processed for histological analysis, and follicle stage counts performed to assess follicle activation. Growing follicles were isolated from the remaining fragments, their diameters recorded using an eyepiece micrometer, and cultured in McCoy’s medium supplemented with 10 ng/ml rhFSH, 50 µg/ml ascorbic acid phosphate (AAP) and 100 ng/ml rhActivin A for 15 days, with media changes and follicle diameter measured every 2 days. Main results and the role of chance All cultured groups showed increased follicle activation compared with fresh tissue. Tissue treated with 0.5 µM TH did not have more growing follicles than control (30.2% ± 8.2 vs 21.3% ± 10.4, respectively), whereas a significant increase was observed in the 2.5 µM TH group (37.5% ± 6.8) (p < 0.05 vs control), indicating that the higher dose promoted increased primordial follicle activation. Secondary follicle characteristics differed depending on dose. Secondary follicles isolated from tissue treated with 0.5 µM TH were larger when isolated (diameter 143.6 µm± 20.3) than those from control tissue (111.7 µm ± 11.4, p = 0.1), whereas follicles from the 2.5 µM TH group were smaller (98.9 µm ± 5.3, p = 0.1). Furthermore, follicles from cortex treated with 0.5 µM TH showed an improved growth rate during culture, with a 37.5% increase in size (p = 0.05 vs control) over 15 days, compared with 18.6% and 17.7% in the 2.5 µM TH and control groups, respectively. These findings provide preliminary evidence that low-dose TH (0.5 µM) may optimise step one of the multi-step system by enhancing both secondary follicle size and growth potential, without significantly increasing primordial follicle activation. Limitations, reasons for caution Ovarian cortical biopsies were obtained from pregnant women undergoing caesarean section. As such, the data obtained may not accurately reflect effect on tissue of non-pregnant women. Furthermore, ovarian fragments show a high degree of variability in follicle number and distribution indicating the need to increase sample size to improve accuracy. Wider implications of the findings These findings provide preliminary evidence supporting the addition of 0.5 µM TH as an effective strategy to enhance growth of follicles isolated following culture of ovarian cortical tissue, thereby providing a more consistent source of secondary follicles, with the ultimate goal of generating mature (MII) oocytes in vitro. Trial registration number No

Zitieren

APA

Ajlan, A., Chibnall, A., Srsen, V., Odey, Y., Anderson, R., & Telfer, E. (2026). L26/P-414 In Vitro Growth of human primordial follicles: Effect of Trigonelline hydrochloride on follicle activation and growth. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.748

Vancouver

Ajlan A, Chibnall A, Srsen V, Odey Y, Anderson R, Telfer E. L26/P-414 In Vitro Growth of human primordial follicles: Effect of Trigonelline hydrochloride on follicle activation and growth. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.748

BibTeX
@article{Ajlan2026,
  author = {Ajlan, A. and Chibnall, A. and Srsen, V. and Odey, Y. and Anderson, R.A. and Telfer, E.E.},
  title = {L26/P-414 In Vitro Growth of human primordial follicles: Effect of Trigonelline hydrochloride on follicle activation and growth},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.748}
}
Kostenlos starten →